Assessment of Frailty in Elderly Patients With Advanced Cancers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

8 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-04

Study Completion Date

2016-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is looking at the feasibility of performing frailty assessments on elderly patients with advanced cancers

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observation on the Frailty Status of Lung Cancer Patients

NCT06448455

Lung Cancer

RECRUITING

Assessment of Patient Frailty Prior to Thoracic Surgery

NCT02803281

Lung Cancer Esophageal Cancer

COMPLETED

Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients

NCT05230888

Lung Cancer Non-small Cell Lung Cancer

WITHDRAWN

Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer

NCT02807129

Cancer

COMPLETED NA

A Single-centre Prospective Study to Explore the Role of Frailty in Patients With Multiple Myeloma.

NCT04683393

Multiple Myeloma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is primarily looking to see if it is feasible to assess frailty in patients age 70 years and above with advanced cancers. it is also evaluating whether there may be any correlation between these assessments and toxicity and treatment and outcome.

The assessments include: Frailty score, nutritional assessment, comorbidity score and quality of life. In addition sarcopenia will be assessed using timed walk, grip strength and muscle mass measurement from imaging performed as part of routine clinical care.

The assessments will be performed at baseline, week 12 and week 24.

There is the option for patients to also donate blood samples for research purposes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histological diagnosis of advanced carcinoma - not suitable for curative treatment
* Age 70 years or over
* seen by an oncologist for consideration of palliative systemic medical therapy and decision regarding management already made
* WHO Performance Status 0-2
* Written informed consent